REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62 | +14.8% | 392 | +2.1% | 0.00% | – |
Q2 2023 | $54 | 0.0% | 384 | +19.3% | 0.00% | – |
Q1 2023 | $54 | -15.6% | 322 | -14.6% | 0.00% | – |
Q4 2022 | $64 | -99.9% | 377 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $71,000 | +208.7% | 377 | +161.8% | 0.00% | – |
Q2 2022 | $23,000 | +35.3% | 144 | +61.8% | 0.00% | – |
Q1 2022 | $17,000 | +142.9% | 89 | +242.3% | 0.00% | – |
Q4 2021 | $7,000 | +133.3% | 26 | +73.3% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q3 2020 | $3,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | – | 15 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |